Outcomes and management of primary tumors in metastatic MSI/dMMR colorectal cancer patients treated with immune checkpoint inhibitors: a cohort study

Background: The optimal management of primary tumor (PT) in microsatellite instability-high metastatic colorectal cancer patients treated with immune checkpoint inhibitors (ICIs) remains unclear. Patients and methods: We retrospectively analyzed a prospective, single-center cohort to assess PT outco...

Descripció completa

Dades bibliogràfiques

Autors principals:	L. Mas, C. Grosnon, T. Samaille, A. Dardenne, Y. Parc, J.H. Lefèvre, R. Cohen, T. André
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2026-06-01
Col·lecció:	ESMO Gastrointestinal Oncology
Matèries:	primary tumor resection metastatic colorectal cancer immune checkpoint inhibitors MSI-H
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2949819826000191
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!